Skip to main content
xMedica

Search

17 studies match these filters. Showing 1–17 of 17 studies

Search results
Registration numberStudyStatusPhaseEnrolmentSites / countriesStart yearLast updatedActions
NCT07674654A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

This is a long-term safety study to evaluate the safety and tolerability of intermittent use of elismetrep in the acute treatment of migraine attacks.

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 113 sites in total

RecruitingPhase 31,000target113 / 12026Aug 27, 2026
NCT07645924A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

This is a double-blind, randomized, multicenter, outpatient evaluation of the efficacy, safety, and tolerability of elismetrep, as compared with placebo, in the acute treatment of migraine.

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 113 sites in total · contact listed

RecruitingPhase 31,800target113 / 12026Aug 20, 2026
NCT06582810Lidocaine Infusion Treatment for Subarachnoid Hemorrhage Headaches

The goal of this observational study is to evaluate intravenous lidocaine efficacy and safety in treating headache following non-traumatic subarachnoid hemorrhage. Through this prospective analysis, the investigators hope to: 1. show that intravenous lidocaine infusion causes a clinically significa…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · contact listed

Recruiting20target1 / 12025Jul 10, 2026
NCT05125302Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting, and sensitivity to light and sound. Migraine is extremely common and disabling in children. The purpose of this study is to evaluate how sa…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 129 sites in total

RecruitingPhase 31,059target129 / 22022Sep 14, 2026
NCT06527222A Study of Ranolazine in ALS

The purpose of this study is to evaluate safety, effect on cramps, function and quality of life of ranolazine versus placebo for the treatment of ALS.

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 6 sites in total · contact listed

RecruitingPhase 272target6 / 12025Jun 8, 2026
NCT06847321Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

This study is to test LHP588 in persons who have mild to moderate Alzheimer's disease (AD) who have shown progressive mental decline in the last year and who have P. gingivalis (Pg) infection. P. gingivalis infection has been linked to the development of dementia. LHP588 is designed to target the P.…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 38 sites in total · contact listed

RecruitingPhase 2300target38 / 12025Sep 15, 2026
NCT06628908Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine (SUZ) in participants with pain associated with diabetic peripheral neuropathy (DPN).

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 76 sites in total

RecruitingPhase 31,100target76 / 12024Jun 15, 2026
NCT01574053Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

Enroll-HD is a longitudinal, observational, multinational study that integrates two former Huntington's disease (HD) registries-REGISTRY in Europe, and COHORT in North America and Australasia-while also expanding to include sites in Latin America. More than 30,000 participants have now enrolled into…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 183 sites in total · contact listed

RecruitingNot verified since Feb 1, 202435,000target183 / 202012Feb 28, 2024
NCT07609108Pridopidine Phase 3 Study in Huntington's Disease

The goal of this clinical trial is to learn if pridopidine can slow the clinical decline of Huntington's Disease (HD) in adult participants. It will also inform about the safety of pridopidine. The main questions the study aims to answer are: Does pridopidine slow the overall worsening of HD over…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 66 sites in total · contact listed

RecruitingPhase 3400target66 / 122026Sep 17, 2026
NCT02523014Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

This phase II trial studies how well vismodegib, focal adhesion kinase (FAK) inhibitor GSK2256098, and capivasertib work in treating patients with meningioma that is growing, spreading, or getting worse (progressive). Vismodegib, FAK inhibitor GSK2256098, capivasertib, and abemaciclib may stop the g…

Contact Claimed

Nearest site: Kingman, Kansas, United States — 28 km away · 783 sites in total

RecruitingPhase 2124target783 / 12015Sep 2, 2026
NCT06990867Optimizing Reperfusion to Improve Outcomes and Neurologic Function

The goal of this study is to evaluate the safety and efficacy of JX10 versus placebo in participants with Acute Ischemic Stroke (AIS) who present for care within 4.5 to 24 hours. The main question the study aims to answer are: 1. JX10 improves functional outcomes as measured by the modified Rankin…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 83 sites in total · contact listed

RecruitingPhase 2 / Phase 3740target83 / 182025Mar 13, 2026
NCT05065216Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)

This is a Phase 2/3 study evaluating the safety and efficacy of DM199 (rinvecalinase alfa) in treating participants with moderate stroke severity, who present within 24 hours of Acute Ischemic Stroke (AIS) onset due to small and medium vessel occlusions. This study focuses on participants with limit…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 86 sites in total · contact listed

RecruitingPhase 2 / Phase 3728target86 / 102021Sep 14, 2026
NCT05561127Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel

To determine the safety and efficacy of GIE Medical's ProTractX3™ TTS DCB for the treatment of recurrent benign bowel strictures.

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 33 sites in total · contact listed

RecruitingPhase 3171target33 / 12023Jun 25, 2025
NCT05491525Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC

The purpose of this study is to evaluate the safety, efficacy, and PK of Vibegron in pediatric participants with NDO who are regularly using CIC

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 38 sites in total · contact listed

RecruitingPhase 2 / Phase 371target38 / 162022Jun 15, 2026
NCT07190300TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

The purpose of the study is to evaluate the safety, tolerability, and efficacy of the two different treatment combinations of tulmimetostat in participants with de novo or recurrent Metastatic Hormone-Sensitive Prostate Cancer (mHSPC).

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 31 sites in total · contact listed

RecruitingPhase 1 / Phase 2181target31 / 142026Jun 23, 2026
NCT07546929HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

Blood sugar levels are controlled by insulin, a hormone made by cells in the pancreas. After a meal, carbohydrates are broken down into glucose which is absorbed from the intestine into the blood leading to a rise in glucose (blood sugar) which triggers the secretion of insulin. Insulin binds to cel…

Contact Claimed

Nearest site: El Dorado, Kansas, United States — 85 km away · 25 sites in total · contact listed

RecruitingPhase 2300target25 / 12023Apr 23, 2026
NCT02402244Project: Every Child for Younger Patients With Cancer

This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 279 sites in total · contact listed

Recruiting75,000target279 / 62015Aug 25, 2026

Filters

Clear all filters